- Home
- RSLS vs FTFT Comparison
RSLS vs FTFT Comparison
Compare RSLS & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- FTFT
- Stock Information
- Founded
- RSLS 2002
- FTFT N/A
- Country
- RSLS United States
- FTFT United States
- Employees
- RSLS N/A
- FTFT N/A
- Industry
- RSLS Medical/Dental Instruments
- FTFT Business Services
- Sector
- RSLS Health Care
- FTFT Consumer Discretionary
- Exchange
- RSLS Nasdaq
- FTFT Nasdaq
- Market Cap
- RSLS 4.5M
- FTFT 3.9M
- IPO Year
- RSLS 2007
- FTFT N/A
- Fundamental
- Price
- RSLS $4.31
- FTFT $1.36
- Analyst Decision
- RSLS Hold
- FTFT
- Analyst Count
- RSLS 1
- FTFT 0
- Target Price
- RSLS N/A
- FTFT N/A
- AVG Volume (30 Days)
- RSLS 101.4K
- FTFT 163.9K
- Earning Date
- RSLS 05-21-2025
- FTFT 05-20-2025
- Dividend Yield
- RSLS N/A
- FTFT N/A
- EPS Growth
- RSLS N/A
- FTFT N/A
- EPS
- RSLS N/A
- FTFT N/A
- Revenue
- RSLS $7,175,000.00
- FTFT $2,031,913.00
- Revenue This Year
- RSLS $52.80
- FTFT N/A
- Revenue Next Year
- RSLS N/A
- FTFT N/A
- P/E Ratio
- RSLS N/A
- FTFT N/A
- Revenue Growth
- RSLS N/A
- FTFT N/A
- 52 Week Low
- RSLS $4.03
- FTFT $1.15
- 52 Week High
- RSLS $414.99
- FTFT $8.19
- Technical
- Relative Strength Index (RSI)
- RSLS 34.73
- FTFT 41.00
- Support Level
- RSLS $4.34
- FTFT $1.46
- Resistance Level
- RSLS $4.95
- FTFT $1.57
- Average True Range (ATR)
- RSLS 0.53
- FTFT 0.15
- MACD
- RSLS 0.19
- FTFT -0.02
- Stochastic Oscillator
- RSLS 10.11
- FTFT 5.65
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.